NCT03573960 2026-03-06
A Study to Evaluate the Safety and Efficacy of Lenvatinib in Participants With Refractory Differentiated Thyroid Cancer
Eisai Inc.
Phase 4 Completed
Clinical Trials
13 trialsNCT06457503 2026-03-02
TRANSPARENT
Coherus Oncology, Inc.
Phase 4 Recruiting
NCT01496313 2025-10-03
To Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid Cancer
Sanofi
Phase 4 Completed
NCT01896479 2025-09-02
EXAMINER
Exelixis
Phase 4 Active not recruiting
NCT04489888 2025-06-19
MK-3475-B10
Merck Sharp & Dohme LLC
Phase 4 Completed
NCT06423235 2024-05-21
ESPTTN
Xintian Pharmaceutical
Phase 4 Not yet recruiting
NCT03123406 2024-04-29
ACTIVE
Kyowa Kirin Co., Ltd.
Phase 4 Completed
NCT05055726 2022-11-16
BOOM
Aziende Chimiche Riunite Angelini Francesco S.p.A
Phase 4 Completed
NCT00858104 2014-05-26
Percutaneous Laser Ablation in Benign Thyroid Nodules.Long Term Results
Elesta S.R.L.
Phase 4 Completed
NCT01283906 2013-09-12
MuGard
Access Pharmaceuticals, Inc.
Phase 4 Completed
NCT00037518 2013-05-08
A Study of an Investigational Medication for Severe Primary Hyperparathyroidism or Parathyroid Cancer
Amgen
Phase 4 Completed
NCT00902122 2012-04-09
rAd-p53 Gene Therapy for Advanced Malignant Thyroid Tumors
Shenzhen SiBiono GeneTech Co.,Ltd
Phase 4 Unknown
NCT00772681 2009-12-07
Tax-Nazo
Sanofi
Phase 4 Completed